NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
10.71
-0.23 (-2.10%)
At close: Jun 27, 2025, 4:00 PM
11.12
+0.41 (3.83%)
After-hours: Jun 27, 2025, 7:39 PM EDT
NeuroPace Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for NeuroPace stock ranges from a low of $8.00 to a high of $18. The average analyst price target of $15.14 forecasts a 41.36% increase in the stock price over the next year.
Price Target: $15.14 (+41.36%)
Analyst Consensus: Buy
* Price targets were last updated on May 28, 2025.
Analyst Ratings
The average analyst rating for NeuroPace stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +68.07% | May 28, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +49.39% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $17 | Buy | Reiterates | $17 | +58.73% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +86.74% | Mar 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $13 → $17 | Buy | Maintains | $13 → $17 | +58.73% | Jan 30, 2025 |
Financial Forecast
Revenue This Year
96.69M
from 79.91M
Increased by 21.00%
Revenue Next Year
108.11M
from 96.69M
Increased by 11.81%
EPS This Year
-0.84
from -0.93
EPS Next Year
-0.62
from -0.84
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 101.8M | 122.9M | 147.0M | ||
| Avg | 96.7M | 108.1M | 136.2M | ||
| Low | 91.1M | 97.7M | 121.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.4% | 27.1% | 36.0% | ||
| Avg | 21.0% | 11.8% | 25.9% | ||
| Low | 14.1% | 1.1% | 12.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.56 | -0.36 | -0.07 | ||
| Avg | -0.84 | -0.62 | -0.28 | ||
| Low | -0.92 | -0.85 | -0.61 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.